Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Meyyappan
Meyyappan Meenakshisundaram, Sammamish, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20090199080 | ADAPTATION OF DISPLAY PAGES FOR CLIENT ENVIRONMENTS - An adaptation system adapts a web page, which is developed to be displayed by a web browser, to be displayed by client-side code of an application. When a web server receives a request for a web page, it determines whether the request was sent from a client device executing client-side code or from a non-client device executing a browser. If the request is from a client, then the web server uses the adaptation system to adapt the web page to the environment of the application. The adaptation system may modify the web page so that the menus of the web page are not displayed when the web page is displayed within a window of the application. The adaptation system may also modify links of the content of the web page to reference forms of the application, rather than other web pages. | 08-06-2009 |
Meyyappan Muthuppalaniappan, Hyderabad IN
| Patent application number | Description | Published |
|---|---|---|
| 20110105447 | NOVEL MODULATORS OF CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL - Disclosed are novel calcium release-activated calcium (CRAC) channel inhibitors, methods for preparing them, pharmaceutical compositions containing them, and methods of treatment using them. The present disclosure also relates to methods for treating non-small cell lung cancer (NSCLC) with CRAC inhibitors, and to methods for identifying therapeutics for treating and of diagnosing cancer. | 05-05-2011 |
| 20110112058 | NOVEL MODULATORS OF CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL AND METHODS FOR TREATMENT OF NON-SMALL CELL LUNG CANCER - Disclosed are novel calcium release-activated calcium (CRAC) channel inhibitors, methods for preparing them, pharmaceutical compositions containing them, and methods of treatment using them. The present disclosure also relates to methods for treating non-small cell lung cancer (NSCLC) with CRAC inhibitors, and to methods for identifying therapeutics for treating and of diagnosing cancer. | 05-12-2011 |
| 20110118257 | NOVEL KINASE MODULATORS - The present invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them. | 05-19-2011 |
Meyyappan Muthuppalaniappan, Navi Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20080200501 | NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION - The present invention relates to novel cannabinoid receptor modulators, in particular cannabinoid 1 (CB1) or cannabinoid 2 (CB2) receptor modulators, and uses thereof for treating diseases, conditions and/or disorders modulated by a cannabinoid receptor (such as pain, neurodegenative disorders, eating disorders, weight loss or control, and obesity). | 08-21-2008 |
| 20080234259 | Novel Cannabinoid Receptor Ligands, Pharmaceutical Compositions Containing Them, and Process For Their Preparation - The present invention relates to novel cannabinoid receptor modulators, in particular cannabinoid 1 (CB1) or cannabinoid 2 (CB2) receptor modulators, and uses thereof for treating diseases, conditions and/or disorders modulated by a cannabinoid receptor (such as pain, neurodegenative disorders, eating disorders, weight loss or control, and obesity). | 09-25-2008 |
Meyyappan Muthuppalniappan, Hyderabad IN
| Patent application number | Description | Published |
|---|---|---|
| 20090325987 | QUINAZOLINEDIONE DERIVATIVES AS TRPA1 MODULATORS - The present invention provides Quinazolinedione derivatives as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1. | 12-31-2009 |